This important study demonstrates that ocular organoids can generate both retina and lens through a non-canonical, "inside-out" morphogenetic route. The work is solid, with well-designed experiments ...
RedChip Companies will air interviews with BioVie Inc. (NASDAQ:BIVI) and FibroBiologics, Inc. (Nasdaq:FBLG) on the RedChip ...
Atrial fibrillation (AF) is the most common sustained arrhythmia, with a rising global burden. While previous studies have ...
Pfizer acquires Metsera for up to $7.3B, aiming to enter the high-growth obesity drug market and diversify its portfolio.
Huntress analysts discovered a previously unseen ransomware variant, Obscura, spreading from a victim company's domain controller. Learn how Obscura works—and what it means for defenders—in this ...
Ocugen (OCGN) is a clinical-stage biotech focused on modifier gene therapies for inherited retinal diseases, with key ...
Technology is advancing at a blistering pace, but adoption is lagging behind. Underwhelming pilots and anxiety over job loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback